United States · FDA National Drug Code directory
IFOSFAMIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10019-925_d505027a-76e6-49f1-8ed1-3eeffe9a958b
- Product NDC
- 10019-925
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- IFOSFAMIDE
- Labeler
- Baxter Healthcare Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 19881230
- Source listing expiry
- 20271231
Source-listed ingredients
- IFOSFAMIDE — 1 g/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-925-01) / 20 mL in 1 VIAL, SINGLE-DOSE (10019-925-82) · 10019-925-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →